Welcome to the DarkDaily.com White Paper Library

An important and useful resource of knowledge and information for the laboratory manager or executive, to help boost lab performance beyond compare! Download any White Paper in our library free of charge and share this unique resource with your team! New reports are added frequently so please check back.

FREE SPECIAL EDITION WHITE PAPER  How to Create a Patient-centered Lab with Breakthrough Blood Collection Technology: Microsampling takes blood collection out of the clinic

FREE SPECIAL EDITION WHITE PAPER
How to Create a Patient-centered Lab with Breakthrough Blood Collection Technology: Microsampling takes blood collection out of the clinic

Breakthrough methods in blood collection technology have the ability to expedite your lab’s move to patient-centered care, as well as answer the challenges of changing remote patient requirements. The Dark Report is pleased to offer this FREE White Paper, an ideal resource for those interested in new microsampling technology—what it is, how it works, and how it can transform your lab.

read more
How Next-Generation Sequencing Helps Molecular Laboratories Deliver Personalized Medicine Services to their Client Physicians

How Next-Generation Sequencing Helps Molecular Laboratories Deliver Personalized Medicine Services to their Client Physicians

Personalized and predictive medicine are rapidly becoming a reality. As a result, your clinical diagnostic laboratory’s need for a laboratory information management system (LIMS) designed to accommodate personalized medicine’s informatics integration and workflow challenges has become vital. The Dark Report is pleased to offer this FREE White Paper, providing a detailed discussion on how you can unlock the potential of next generation sequencing (NGS) technology in your lab, and the benefits and contributions it can make to add clinical value and improve patient care.

read more
The Laboratory Executive’s Guide to Maximizing Revenue & Valuation: Effective Revenue Cycle and Compliance Management are Critical Success Factors

The Laboratory Executive’s Guide to Maximizing Revenue & Valuation: Effective Revenue Cycle and Compliance Management are Critical Success Factors

The laboratory business continues to face consolidation and margin pressure, with far fewer independent labs now than just a decade ago. A laboratory’s financial success and valuation is all about top line revenue, profitability, and minimizing risk— elements that can be positively impacted by state-of-the-art revenue cycle management. Oversight of the entire revenue cycle, by conducting a constant and consistent analysis of the front-to-back end revenue processes through specific tools and workflows, can maximize the efficiency and adaptability of all of the components of the revenue cycle process to net the greatest return.

read more
A Lab Leader’s Guide To Pharmacogenomic Testing (PGx)

A Lab Leader’s Guide To Pharmacogenomic Testing (PGx)

The Dark Report is pleased to offer this FREE White Paper, providing an enlightening overview of pharmacogenomic testing and how PGx fits into current healthcare goals, a discussion of the obstacles healthcare providers, institutions and clinical diagnostic laboratories face in entering the pharmacogenomic testing market, and examples of how a cloud-based, Software-as-a-Service platform can help healthcare providers overcome those obstacles.

read more
3 Critical Rules for Surviving in 2017: Your Medical Laboratory’s Guide to Thriving in Today’s Healthcare Landscape

3 Critical Rules for Surviving in 2017: Your Medical Laboratory’s Guide to Thriving in Today’s Healthcare Landscape

With less revenue flowing from reimbursements and more consumers footing the bill for diagnostic testing, counterbalancing lost revenue while better serving providers and patients is not an option—it is a must. The Dark Report is pleased to offer this FREE White Paper, exploring three critical rules innovative medical laboratories must take into account to combat new and drastic changes occurring in the lab industry, and outlining proactive steps that when taken, will serve as the foundation for clinical success in 2017 and beyond.

read more
How Clinical Laboratories and Pathology Groups Can Succeed in Pharmacogenomics: What the Experts are Saying

How Clinical Laboratories and Pathology Groups Can Succeed in Pharmacogenomics: What the Experts are Saying

Increasing understanding of the genetic basis of an individual’s response to drugs, including how and how quickly a drug is metabolized (pharmacodynamics and pharmacokinetics), has opened the door to an increasingly personalized approach to drug prescription. By identifying drugs most likely to benefit a patient, assessing the likely dose response, potentially avoiding adverse reactions, and reducing unnecessary use of drugs,  pharmacogenomics testing (PgX) is helping to optimize treatment and reduce costs associated with complications or inappropriate utilization.

read more
Molecular Information Management Systems (MIMS): Pathologists are Using MIMS To Revolutionize Personalized and Predictive Medicine

Molecular Information Management Systems (MIMS): Pathologists are Using MIMS To Revolutionize Personalized and Predictive Medicine

As molecular technology and personalized medicine increasingly becomes the default position for clinical diagnostics laboratories, these modalities place significant demands on laboratory information systems. Although hospitals and healthcare institutions often focus on an enterprise-wide electronic medical records system that includes a laboratory information system (LIS), those LIS’s do not typically have the functionality needed to handle current molecular testing needs, let alone those expected in the near future.

read more
3 Ways Labs Can Increase Revenue and Gain a Competitive Advantage in the Marketplace

3 Ways Labs Can Increase Revenue and Gain a Competitive Advantage in the Marketplace

In an increasingly competitive healthcare landscape, laboratories must vie for a share of the nearly 6.1 billion clinical lab tests performed annually in the United States. As independent and hospital-based medical laboratories navigate against the headwinds of shrinking reimbursement levels, it is critical for your laboratory to strengthen relationships with current clientele and grow your client base.

read more
Augmenting an Enterprise-Wide HIT System with a Best-of-Breed Anatomic Pathology LIS

Augmenting an Enterprise-Wide HIT System with a Best-of-Breed Anatomic Pathology LIS

The Dark Report is pleased to offer this FREE White Paper providing you with a detailed discussion on the considerations of investing in a best-of-breed anatomic pathology-specific laboratory information system, and the reasons why even a solid enterprise-wide EHR and/or LIS solution may be insufficient for the complexities of your anatomic pathology (AP) laboratory and its distinct needs in terms of workflow, data mining, imaging and results formats.

read more
A CEO’s Guide to Doubling Profitability: Using Technology to Reduce Back-Office Costs

A CEO’s Guide to Doubling Profitability: Using Technology to Reduce Back-Office Costs

The ultimate goal of any commercial venture is to increase profitability. Significantly increasing overall profitability frequently requires substantial changes to a business (e.g., mergers/ acquisitions, in-licensing or developing new products, or divestiture of unprofitable business units). Building on earlier white papers in the CEO’s Guide series, this white paper will look at relatively benign changes that clinical laboratory management can undertake. Although less dramatic than other options, they can still result in a doubling of lab profitability.

read more
A CEO’s Guide to Next Generation Revenue Cycle Management: What Service Providers Need to Know to Survive the Changing Diagnostic Healthcare Environment

A CEO’s Guide to Next Generation Revenue Cycle Management: What Service Providers Need to Know to Survive the Changing Diagnostic Healthcare Environment

Macroeconomic pressure, increased governance, organizational changes, and technological advances are driving pervasive and lasting changes in the fabric of the healthcare system. Because diagnostic services influence the majority of healthcare decisions, changes to healthcare are magnified in the diagnostic services segment. Failure to aggressively adapt to this dynamic environment can easily imperil diagnostic service providers.

read more
A CEO’s Guide to Molecular Diagnostic Reimbursement: Navigating the Many Challenges of Reimbursement and Commercialization

A CEO’s Guide to Molecular Diagnostic Reimbursement: Navigating the Many Challenges of Reimbursement and Commercialization

Reimbursement and commercialization are significant challenges in this era of personalized medicine and comparative effectiveness. Many traditional clinical laboratories and early stage startup companies are trying to enter this space and are struggling to evaluate both the market and its offerings. According to Gene Tests, a publicly funded medical genetics information resource, the availability of new diagnostic tests increases 10% annually. However, there is a 20% increase in the utilization of genetic tests per year versus a 1% to 3% increase in non-genetic diagnostic tests per year.

read more

A Lab Leader’s Guide To Pharmacogenomic Testing (PGx)

The Dark Report is pleased to offer this FREE White Paper, providing an enlightening overview of pharmacogenomic testing and how PGx fits into current healthcare goals, a discussion of the obstacles healthcare providers, institutions and clinical diagnostic laboratories face in entering the pharmacogenomic testing market, and examples of how a cloud-based, Software-as-a-Service platform can help healthcare providers overcome those obstacles.

read more

3 Critical Rules for Surviving in 2017: Your Medical Laboratory’s Guide to Thriving in Today’s Healthcare Landscape

With less revenue flowing from reimbursements and more consumers footing the bill for diagnostic testing, counterbalancing lost revenue while better serving providers and patients is not an option—it is a must. The Dark Report is pleased to offer this FREE White Paper, exploring three critical rules innovative medical laboratories must take into account to combat new and drastic changes occurring in the lab industry, and outlining proactive steps that when taken, will serve as the foundation for clinical success in 2017 and beyond.

read more

How Clinical Laboratories and Pathology Groups Can Succeed in Pharmacogenomics: What the Experts are Saying

Increasing understanding of the genetic basis of an individual’s response to drugs, including how and how quickly a drug is metabolized (pharmacodynamics and pharmacokinetics), has opened the door to an increasingly personalized approach to drug prescription. By identifying drugs most likely to benefit a patient, assessing the likely dose response, potentially avoiding adverse reactions, and reducing unnecessary use of drugs,  pharmacogenomics testing (PgX) is helping to optimize treatment and reduce costs associated with complications or inappropriate utilization.

read more

Molecular Information Management Systems (MIMS): Pathologists are Using MIMS To Revolutionize Personalized and Predictive Medicine

As molecular technology and personalized medicine increasingly becomes the default position for clinical diagnostics laboratories, these modalities place significant demands on laboratory information systems. Although hospitals and healthcare institutions often focus on an enterprise-wide electronic medical records system that includes a laboratory information system (LIS), those LIS’s do not typically have the functionality needed to handle current molecular testing needs, let alone those expected in the near future.

read more

3 Ways Labs Can Increase Revenue and Gain a Competitive Advantage in the Marketplace

In an increasingly competitive healthcare landscape, laboratories must vie for a share of the nearly 6.1 billion clinical lab tests performed annually in the United States. As independent and hospital-based medical laboratories navigate against the headwinds of shrinking reimbursement levels, it is critical for your laboratory to strengthen relationships with current clientele and grow your client base.

read more

Augmenting an Enterprise-Wide HIT System with a Best-of-Breed Anatomic Pathology LIS

The Dark Report is pleased to offer this FREE White Paper providing you with a detailed discussion on the considerations of investing in a best-of-breed anatomic pathology-specific laboratory information system, and the reasons why even a solid enterprise-wide EHR and/or LIS solution may be insufficient for the complexities of your anatomic pathology (AP) laboratory and its distinct needs in terms of workflow, data mining, imaging and results formats.

read more

A CEO’s Guide to Doubling Profitability: Using Technology to Reduce Back-Office Costs

The ultimate goal of any commercial venture is to increase profitability. Significantly increasing overall profitability frequently requires substantial changes to a business (e.g., mergers/ acquisitions, in-licensing or developing new products, or divestiture of unprofitable business units). Building on earlier white papers in the CEO’s Guide series, this white paper will look at relatively benign changes that clinical laboratory management can undertake. Although less dramatic than other options, they can still result in a doubling of lab profitability.

read more

A CEO’s Guide to Next Generation Revenue Cycle Management: What Service Providers Need to Know to Survive the Changing Diagnostic Healthcare Environment

Macroeconomic pressure, increased governance, organizational changes, and technological advances are driving pervasive and lasting changes in the fabric of the healthcare system. Because diagnostic services influence the majority of healthcare decisions, changes to healthcare are magnified in the diagnostic services segment. Failure to aggressively adapt to this dynamic environment can easily imperil diagnostic service providers.

read more

A CEO’s Guide to Molecular Diagnostic Reimbursement: Navigating the Many Challenges of Reimbursement and Commercialization

Reimbursement and commercialization are significant challenges in this era of personalized medicine and comparative effectiveness. Many traditional clinical laboratories and early stage startup companies are trying to enter this space and are struggling to evaluate both the market and its offerings. According to Gene Tests, a publicly funded medical genetics information resource, the availability of new diagnostic tests increases 10% annually. However, there is a 20% increase in the utilization of genetic tests per year versus a 1% to 3% increase in non-genetic diagnostic tests per year.

read more